Biton J - Search Results

1

A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis.

Veenbergen S, Bennink MB, Affandi AJ, Bessis N, Biton J, Arntz OJ, van den Berg WB, van de Loo FA. Veenbergen S, et al. Among authors: biton j. Ann Rheum Dis. 2011 Dec;70(12):2167-75. doi: 10.1136/ard.2011.154815. Epub 2011 Aug 27. Ann Rheum Dis. 2011. PMID: 21873688

2

Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.

Miellot-Gafsou A, Biton J, Bourgeois E, Herbelin A, Boissier MC, Bessis N. Miellot-Gafsou A, et al. Among authors: biton j. Immunology. 2010 Jun;130(2):296-306. doi: 10.1111/j.1365-2567.2009.03235.x. Epub 2010 Jan 27. Immunology. 2010. PMID: 20113367 Free PMC article.

3

Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice.

Thiolat A, Denys A, Petit M, Biton J, Lemeiter D, Herve R, Lutomski D, Boissier MC, Bessis N. Thiolat A, et al. Among authors: biton j. Cytokine. 2014 Sep;69(1):87-93. doi: 10.1016/j.cyto.2014.05.015. Epub 2014 Jun 11. Cytokine. 2014. PMID: 25022966

4

Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.

Athari SK, Poirier E, Biton J, Semerano L, Hervé R, Raffaillac A, Lemeiter D, Herbelin A, Girard JP, Caux F, Boissier MC, Bessis N. Athari SK, et al. Among authors: biton j. Arthritis Res Ther. 2016 Jun 18;18(1):143. doi: 10.1186/s13075-016-1042-x. Arthritis Res Ther. 2016. PMID: 27317338 Free PMC article.

5

In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis.

Biton J, Khaleghparast Athari S, Thiolat A, Santinon F, Lemeiter D, Hervé R, Delavallée L, Levescot A, Roga S, Decker P, Girard JP, Herbelin A, Boissier MC, Bessis N. Biton J, et al. J Immunol. 2016 Sep 1;197(5):1708-19. doi: 10.4049/jimmunol.1502124. Epub 2016 Jul 29. J Immunol. 2016. PMID: 27474075

6

TNFα: activator or inhibitor of regulatory T cells?

Biton J, Boissier MC, Bessis N. Biton J, et al. Joint Bone Spine. 2012 Mar;79(2):119-23. doi: 10.1016/j.jbspin.2011.09.017. Epub 2011 Dec 29. Joint Bone Spine. 2012. PMID: 22209316 Review.

7

Regulatory T cells (Treg) in rheumatoid arthritis.

Boissier MC, Assier E, Biton J, Denys A, Falgarone G, Bessis N. Boissier MC, et al. Among authors: biton j. Joint Bone Spine. 2009 Jan;76(1):10-4. doi: 10.1016/j.jbspin.2008.08.002. Epub 2008 Nov 22. Joint Bone Spine. 2009. PMID: 19028128 Review.

8

Origins of rheumatoid arthritis.

Boissier MC, Biton J, Semerano L, Decker P, Bessis N. Boissier MC, et al. Among authors: biton j. Joint Bone Spine. 2020 Jul;87(4):301-306. doi: 10.1016/j.jbspin.2019.11.009. Epub 2019 Dec 5. Joint Bone Spine. 2020. PMID: 31812725

9

Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis.

Biton J, Semerano L, Delavallée L, Lemeiter D, Laborie M, Grouard-Vogel G, Boissier MC, Bessis N. Biton J, et al. J Immunol. 2011 Apr 1;186(7):3899-910. doi: 10.4049/jimmunol.1003372. Epub 2011 Feb 23. J Immunol. 2011. PMID: 21346237

10

Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.

Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, Quentin J, Jorgensen C, Decker P, Boissier MC, Louis-Plence P, Bessis N. Thiolat A, et al. Among authors: biton j. Arthritis Rheumatol. 2014 Feb;66(2):273-83. doi: 10.1002/art.38246. Arthritis Rheumatol. 2014. PMID: 24504799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters